Delivery Order SPE2DE24DA017-SPE2D625F1GNQ
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $5,775 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of July 28, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies, received a $3,300 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, which carries an ultimate completion date of September 3, 2025, represents a task order issued against Arthrex's substantial indefinite delivery contract with the Defense Logistics Agency valued at approximately $471...
- Arthrex Inc. was awarded a $4,950 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the Arthrex ACP Double Syringe System, with an ultimate completion date of July 24, 2025. The award represents a non-set-aside contract and is being performed at Arthrex's Naples, Florida location. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics...
- Arthrex Inc., a leading global orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $8,664.00 fixed-price delivery order for the ARTHREX ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. The delivery order, which carries an ultimate completion date of July 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) valued at $471,048,172.66 and running through...
- Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation,...
- Arthrex Inc. has been awarded a delivery order valued at $16,500 for the Arthrex ACP Double Syringe System under a fixed-price contract with economic price adjustment provisions. The award, issued on August 1, 2025, with an ultimate completion date of August 6, 2025, was made by the Defense Logistics Agency's Medical Supply Chain to support federal healthcare requirements. The work will be performed in Naples, Florida, where Arthrex maintains its headquarters. This delivery order was not set...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $17,602.20 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for ARTHREX ACP DOUBLE 1S products. This delivery order, without set-aside designation, is expected to be completed by August 27, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency,...
- The U.S. Department of Defense's Medical Supply Chain awarded Arthrex Inc. a $8,250 fixed-price delivery order for the Arthrex ACP Double Syringe System, with an ultimate completion date of August 19, 2025. This delivery order, issued on August 14, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, valued at $471 million and running through September 1, 2029. The contract involves no set-aside designation, reflecting...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $1,376.10 for an ACP Kit Series II from the Defense Logistics Agency's Medical Supply Chain on August 8, 2025. This fixed-price delivery order with economic price adjustment reflects a task order under Arthrex's significant Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and extending through September...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F1GNQDelivery Order
Arthrex Inc., a Naples, Florida-based orthopedic medical technology company, received a $4,950 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 19, 2025, for the Arthrex ACP Double Syringe System. The contract, classified as a non-set-aside delivery order with an ultimate completion date of August 22, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 2029. This IDC enables Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide to procure Arthrex's comprehensive portfolio of orthopedic surgical technologies and devices. The ACP Double Syringe System delivery aligns with Arthrex's core business of providing minimally invasive orthopedic surgical solutions, including implants, instruments, and biologics to government healthcare systems. As a market leader in federal orthopedic procurement, Arthrex has consistently demonstrated its competitive position through multiple contract awards from the Defense Logistics Agency and Veterans Integrated Service Networks. The company's products typically include arthroscopic instruments, joint replacement systems, suture anchors, and specialized surgical kits designed to support orthopedic procedures across the VA and DoD healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/19/25 |